BMRN and FOLD Related Headlines
Go Back- BioMarin to acquire Amicus Therapeutics for $4.8 billion
- BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

